MADAM

Not to be confused with MADAM-6.
MADAM
Clinical data
Other namesN,N-Dimethyl-2-(2-amino-4-methylphenylthio)benzylamine
Drug classSerotonin reuptake inhibitor
ATC code
  • None
Identifiers
  • 2-[2-[(dimethylamino)methyl]phenyl]sulfanyl-5-methylaniline
PubChem CID
ChEMBL
Chemical and physical data
FormulaC16H20N2S
Molar mass272.41 g·mol−1
3D model (JSmol)
  • CC1=CC(=C(C=C1)SC2=CC=CC=C2CN(C)C)N
  • InChI=1S/C16H20N2S/c1-12-8-9-16(14(17)10-12)19-15-7-5-4-6-13(15)11-18(2)3/h4-10H,11,17H2,1-3H3
  • Key:UABIXNSHHIMZEP-UHFFFAOYSA-N

MADAM, also known as N,N-dimethyl-2-(2-amino-4-methylphenylthio)benzylamine, is a highly potent and selective serotonin reuptake inhibitor (SRI) which is used in scientific research.[1] Its affinity (Kd) for the serotonin transporter (SERT) is 60 pM (0.06 nM).[1] Radiolabeled isotopologues of MADAM have been developed and used as radiotracers in positron emission tomography (PET) imaging.[2][3][4][5] The drug was first described in the scientific literature by 2001.[6][7]

References

  1. ^ a b Chalon S, Tarkiainen J, Garreau L, Hall H, Emond P, Vercouillie J, et al. (January 2003). "Pharmacological characterization of N,N-dimethyl-2-(2-amino-4-methylphenyl thio)benzylamine as a ligand of the serotonin transporter with high affinity and selectivity". The Journal of Pharmacology and Experimental Therapeutics. 304 (1): 81–87. doi:10.1124/jpet.102.042226. PMID 12490578.
  2. ^ Tarkiainen J, Vercouillie J, Emond P, Sandell J, hiltunen J, Frangin Y, et al. (2001). "Carbon-11 labelling of MADAM in two different positions: a highly selective PET radioligand for the serotonin transporter". Journal of Labelled Compounds and Radiopharmaceuticals. 44 (14): 1013–1023. doi:10.1002/jlcr.523. ISSN 0362-4803.
  3. ^ Larsen AK, Brennum LT, Egebjerg J, Sánchez C, Halldin C, Andersen PH (March 2004). "Selectivity of (3)H-MADAM binding to 5-hydroxytryptamine transporters in vitro and in vivo in mice; correlation with behavioural effects". British Journal of Pharmacology. 141 (6): 1015–1023. doi:10.1038/sj.bjp.0705693. PMC 1574267. PMID 14993096.
  4. ^ Halldin C, Lundberg J, Sóvágó J, Gulyás B, Guilloteau D, Vercouillie J, et al. (December 2005). "[(11)C]MADAM, a new serotonin transporter radioligand characterized in the monkey brain by PET". Synapse. 58 (3). New York, N.Y.: 173–183. doi:10.1002/syn.20189. PMID 16138320.
  5. ^ Lundberg J, Odano I, Olsson H, Halldin C, Farde L (September 2005). "Quantification of 11C-MADAM binding to the serotonin transporter in the human brain". Journal of Nuclear Medicine. 46 (9): 1505–1515. PMID 16157534.
  6. ^ Guilloteau D, Tarkiainen J, Garreau L, Vercouillie J, Emond P, Besnard JC, et al. (August 2001). "Pharmacological characterization of N, N-dimethyl-2 (2-amino-4-methylphenylthio) benzylamine or MADAM as a radioligand of the serotonin transporter with high affinity and selectivity". European Journal of Nuclear Medicine. 28 (8): 997.
  7. ^ Chalon S, Tarkiainen J, Garreau L, Hall H, Emond P, Vercouillie J, et al. (July 2002). "N,N-dimethyl-2-(2-amino-4-methylphenylthio) benzylamine or MADAM is a serotonin transporter ligand with high affinity and specificity: in vitro characterization". NeuroImage. 16 (3): S18.
Stub icon

This drug article relating to the nervous system is a stub. You can help Wikipedia by adding missing information.

Content Disclaimer

Informasi ini disarikan dari Wikipedia dan disajikan kembali untuk tujuan edukasi. Konten tersedia di bawah lisensi CC BY-SA 3.0. Kami tidak bertanggung jawab atas ketidakakuratan data yang bersumber dari kontribusi publik tersebut.

  1. The information displayed on this website is sourced in part or in whole from Wikipedia and has been adapted for the purpose of restating it. We strive to provide accurate and relevant information, however:
  2. There is no guarantee of absolute accuracy. Wikipedia is an open, collaborative project that can be edited by anyone, so information is subject to change.
  3. It is not intended to constitute professional advice. The content displayed is for informational and educational purposes only. For important decisions (e.g., medical, legal, or financial), please consult a professional.
  4. Content copyright. Wikipedia is licensed under the Creative Commons Attribution-ShareAlike License (CC BY-SA). This means that content may be reused with appropriate attribution and shared under a similar license.
  5. Responsible use. Any risk arising from the use of information from this website is entirely the responsibility of the user.